Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition letter

Gabrielle S. Wong, Jin Zhou, Jie Bin Liu, Zhong Wu, Xinsen Xu, Tianxia Li, David Xu, Steven E. Schumacher, Jens Puschhof, James McFarland, Charles Zou, Austin Dulak, Les Henderson, Peng Xu, Emily O'Day, Rachel Rendak, Wei Li Liao, Fabiola Cecchi, Todd Hembrough, Sarit SchwartzChristopher Szeto, Anil K. Rustgi, Kwok Kin Wong, J. Alan Diehl, Karin Jensen, Francesco Graziano, Annamaria Ruzzo, Shaunt Fereshetian, Philipp Mertins, Steven A. Carr, Rameen Beroukhim, Kenichi Nakamura, Eiji Oki, Masayuki Watanabe, Hideo Baba, Yu Imamura, Daniel Catenacci, Adam J. Bass

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition letter'. Together they form a unique fingerprint.

Keyphrases

Biochemistry, Genetics and Molecular Biology